IL330201A - Peptide for treating psoriasis vulgaris or psoriatic arthritis - Google Patents

Peptide for treating psoriasis vulgaris or psoriatic arthritis

Info

Publication number
IL330201A
IL330201A IL330201A IL33020126A IL330201A IL 330201 A IL330201 A IL 330201A IL 330201 A IL330201 A IL 330201A IL 33020126 A IL33020126 A IL 33020126A IL 330201 A IL330201 A IL 330201A
Authority
IL
Israel
Prior art keywords
peptide
psoriatic arthritis
treating psoriasis
psoriasis vulgaris
vulgaris
Prior art date
Application number
IL330201A
Other languages
Hebrew (he)
Inventor
Andreas Klostermann
Edvin Nasedy Munk
Original Assignee
SelectION Therapeutics GmbH
Andreas Klostermann
Edvin Nasedy Munk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SelectION Therapeutics GmbH, Andreas Klostermann, Edvin Nasedy Munk filed Critical SelectION Therapeutics GmbH
Publication of IL330201A publication Critical patent/IL330201A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL330201A 2023-12-21 2024-12-20 Peptide for treating psoriasis vulgaris or psoriatic arthritis IL330201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP23219126 2023-12-21
EP23219128 2023-12-21
PCT/EP2024/087932 WO2025133137A1 (en) 2023-12-21 2024-12-20 Peptide for treating psoriasis vulgaris or psoriatic arthritis

Publications (1)

Publication Number Publication Date
IL330201A true IL330201A (en) 2026-08-01

Family

ID=94283964

Family Applications (1)

Application Number Title Priority Date Filing Date
IL330201A IL330201A (en) 2023-12-21 2024-12-20 Peptide for treating psoriasis vulgaris or psoriatic arthritis

Country Status (4)

Country Link
CN (1) CN122497510A (en)
AU (1) AU2024405978A1 (en)
IL (1) IL330201A (en)
WO (1) WO2025133137A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201408135D0 (en) * 2014-05-08 2014-06-25 Conogenetix Biosciences Gmbh Kv1.3 potassium channel antagonists
US20180264080A1 (en) * 2015-01-09 2018-09-20 Kineta One, Llc TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION
WO2018013483A1 (en) * 2016-07-11 2018-01-18 The California Institute For Biomedical Research Kv1.3 channel blocking peptides and uses thereof

Also Published As

Publication number Publication date
AU2024405978A1 (en) 2026-07-30
CN122497510A (en) 2026-07-31
WO2025133137A1 (en) 2025-06-26